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Abstract: The objective was to develop an elemene oil/water (o/w) microemulsion and evalu-
ate its characteristics and oral relative bioavailability in rats. Elemene was used as the oil phase 
and drug, polysorbate 80 as a surfactant along with ethanol, propylene glycol, and glycerol 
as the cosurfactants. The microemulsion was prepared by mixing method, or ultrasonication 
method in an ultrasonic bath. Its three-dimensional response surface diagram was drawn by 
Mathcad software. The microemulsion was characterized by visual observation, cross-polarized 
microscopy, size, zeta potential, acidity, viscosity, and surface tension measurement. The drug 
content and entrapment efficiency were determined by ultra fast liquid chromatography (UFLC) 
and liquid surface method. Blood was drawn from rats at different time points after oral admin-
istration of an elemene microemulsion or a commercial elemene emulsion for measurement of 
the drug in plasma by UFLC to establish the pharmacokinetic parameters and relative bioavail-
ability. The elemene microemulsion as a clarified and isotropic system containing 1% elemene 
(w/v), 5% ethanol (v/v), 15% propylene glycol (v/v), 15% glycerol (v/v), and 5% polysorbate 
80 (w/v), was characterized as (57.7 ± 2.8) nm in size, 0.485 ± 0.032 in polydispersity index, 
(3.2 ± 0.4) mv in zeta potential, (5.19 ± 0.08) in pH, 6 mpa⋅s in viscosity, (31.8 ± 0.3) mN⋅m-1 
in surface tension, (8.273 ± 0.018) mg⋅mL-1 in content of β-elemene, and (99.81 ± 0.24)% in 
average entrapment efficiency. The area under the concentration-time curves from 0 h to 24 h 
(AUC0→24h) of the elemene microemulsion and commercial elemene emulsion were integrated 
to be 3.092 mg⋅h⋅L-1 and 1.896 mg⋅h⋅L-1 respectively, yielding a relative bioavailability of 
163.1%. The present study demonstrates the elemene microemulsion as a new formulation with 
ease of preparation, high entrapment efficiency, excellent clarity, good stability, and improved 
bioavailability.
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Introduction
Elemene is a mixture of sesquiterpene compounds extracted from ginger plants 
  curcuma, with outstanding advantages of a broad anti-tumor spectrum, curative effect, 
and less adverse reaction.1 Recently elemene emulsion has been used widely in clinical 
treatment for malignant effusions, lung cancer, gastrointestinal cancer, brain cancer, 
gynecological cancer, breast cancer, skin cancer, and other tumors.2,3 Among its three 
major components of β, γ, δ isomers, β-elemene is the main active ingredient2 and thus 
used commonly for content determination of elemene. Elemene is a volatile oil with 
poor oral absorption and low bioavailability,4 limiting its clinical applications.
Microemulsion is a transparent or translucent preparation with low viscosity, good 
isotropic and thermodynamic stability upon spontaneous formation in appropriate International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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proportion of an oil phase and a water phase, along with 
surfactants and   cosurfactants. As a drug carrier system for 
oral,   transdermal and   ophthalmic administrations, it has 
certain advantages: (1) ease of preparation, filtration and 
preservation; (2) simultaneous solubilization of drugs of 
different levels of lipophilicity; (3) good drug dispersion, 
absorption, and bioavailability; (4) extended release time 
of water-soluble drugs; (5) low viscosity and no injection 
pain.5,6 O/W microemulsion drug delivery system has 
been normally used via oral and parenteral administra-
tion.7   However, the surfactants of oral microemulsion may 
  stimulate gastrointestinal mucosa and cause changes in 
mucosal permeability leading to systemic chronic toxicity 
in long-term use. The cosurfactants may also cause some 
irritation and pharmacological activity that could limit clini-
cal use of the oral microemulsion.8 So, we aimed to develop 
an oral elemene microemulsion formulation with excellent 
clarity, high entrapment efficiency, good patient compliance, 
and improved bioavailability while meeting the demand of 
facile industrial production. In this paper we describe the 
preparation, characteristics, and relative bioavailability of 
oral elemene o/w microemulsion.
Materials and methods
Instruments and materials
XR-UFLC equipped with a C18 column (2.2 µm, 75 mm × 
3.0 mm) was purchased from Shimadzu Corporation (Tokyo, 
Japan). KQ5200B Ultrasonic cleaner (200 watt) was from 
Kunshan Ultrasound Instruments Co, Ltd   (Kunshan, 
Shanghai, China). Sigma 3k30 Centrifuge was from 
Sartorius Company (Göttingen, German). Nikon E600 POL 
cross-  polarized light microscopy was from Nikon Co. (Tokyo, 
Japan). Zetasizer 3000HS nano size and potential analyzer 
was from Malvern Instruments Ltd. (Malvern, Worcestershire, 
England). DELTA320 pH meter was from Mettler-Toledo Co. 
(Zurich, Switzerland). NDJ-5S digital viscometer and BZY-A 
automatic surface tension meter were from Shanghai Ruifang 
Instrument Co, Ltd   (Shanghai, China). Disposable needle 
filters (0.22 µm) were from Shanghai Xingya Purification 
Material Factory (Shanghai, China). β-elemene standard was 
from National Institute for the Control of Pharmaceutical and 
Biological Products (No. 100268-200401, Beijing, China). 
Elemene crude drug and oral emulsions (0.2 g/20 mL, No. 
0904231) were from Dalian Holley King Kong Pharmaceuti-
cal Co. Ltd (Dalian, Liaoning, China). Acetonitrile was from 
Merck & Co.   (Darmstadt, Germany). Sprague Dawley rats 
were from Zhejiang Academy of Medical Sciences (Cer-
tificate of Conformity: SCXK(Zhe) 2008-0033, Hangzhou, 
Zhejiang, China). Experimental animals were treated accord-
ing to Guideline of Laboratory Animal Care from Chinese 
Ministry of Science and Technology in 2006.9
Three-dimensional response surface 
diagram of elemene microemulsion
Elemene was used as the oil phase and drug, polysorbate 
80 as the surfactant along with ethanol, propylene glycol 
as the cosurfactants, and glycerol as the tackifier and 
absorption enhancer. The amount of elemene and glycerol 
were fixed at 0.4 g and 6 mL respectively. Various volumes 
of ethanol (0, 2, 4, 6, 8 mL) and propylene glycol (0, 2, 
4, 6, 8 mL) at a total of 25 combinations were taken to 
prepare elemene microemulsions. At 25°C, a mixture of 
elemene, ethanol, propylene glycol, and glycerol was 
added into 25 mL of water, followed by dropwise addi-
tion of polysorbate 80 and mixing or ultrasonication until 
the formation of a clarified system. The final volume was 
adjusted to 50 mL. In this process we found that these 
elemene microemulsions were easily formed by mixing 
method, but more easily by ultrasonication in an ultrasonic 
bath for greater clarity. So, we selected the ultrasonication 
in an ultrasonic bath to prepare these elemene microemul-
sions. The minimal amounts of polysorbate 80 required 
to maintain a clarified microemulsion in all 25 cases of 
ethanol-propylene glycol mixture was noted and used to 
construct the three-  dimensional response surface diagram 
of elemene microemulsion by Mathcad 2001 software 
(Figure 1). The diagram shows that the minimal amount of 
polysorbate 80 for forming a   microemulsion is decreased 
with increasing amounts of ethanol and propylene glycol. 
We were concerned with the safety issue of elemene micro-
emulsion for the major side effects of oral polysorbate 80 
over ethanol and propylene glycol and thus selected an 
elemene microemulsion with the lower dose of polysorbate 
80 for further study.
Preparation and characterization  
of elemene microemulsion
According to the three-dimensional response surface 
diagram of elemene microemulsion, an optimal elemene 
microemulsion with minimal amount of polysorbate 80 
was prepared. First, a mixture containing 1 g of elemene, 
15 mL of glycerol, 5 mL of ethanol, 15 mL of propylene 
glycol, and 5 g of polysorbate 80 was added into 60 mL of 
water, followed by 1 h of ultrasonication in an ultrasonic 
bath and a volume adjustment to 100 mL with water. The 
isotropic nature of the microemulsion was examined using International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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cross-polarized light microscopy. Isotropic material, such as 
a   microemulsion, does not interfere with the polarized light 
and should appear dark under cross-polarized microscope.10 
The average particle size, polydispersity index, zeta potential, 
acidity, viscosity, and surface tension of this microemulsion 
were measured. Test temperature was 25°C in all cases.
stability of elemene microemulsion
The elemene emulsion and microemulsion were centrifuged 
at 25°C and 3000× g and 50000× g respectively, for 30 min 
and followed by an examination for phase separation.
UFLc analysis of elemene microemulsion
According to the literature,11 the drug content was detected 
by UFLC. The chromatographic conditions were set as 
  follows: C18 column (2.2 µm, 75 mm × 3.0 mm), acetonitrile/
water (80:20) as mobile phase, 40°C as column temperature, 
210 nm as detection wavelength, 1.0 mL⋅min-1 as flow rate, 
and 5 µL as injection volume. β-elemene standard was 
used as the external standard. Under such chromatographic 
conditions, the theoretical plate number of β-elemene was 
9658 while the retention time of β-elemene was about 
4.8 min. No peak was found for a blank microemulsion 
without elemene at this retention time, indicating a specific 
detection of β-elemene. The standard curve of β-elemene 
concentration was linear in the range of 3.94–27.58 µg⋅mL-1 
with a   regression equation of Y = 2157.8318 * C - 311.4286 
(r = 0.9996). The limit of detection and quantification was 
0.6 ng and 2 ng respectively.
Content and entrapment efficiency  
of β-elemene in elemene microemulsion
To determine the drug content of elemene microemulsion, 
0.1 mL of the elemene microemulsion was taken and diluted 
to 50 mL with 80% acetonitrile aqueous solution. 1 mL of 
this sample solution was detected by UFLC and repeated 
twice as above.
To determine the entrapment efficiency of β-elemene in 
elemene microemulsion, we compared the gel column chroma-
tography and liquid surface method. As the column chromatog-
raphy method had more errors, the liquid surface method was 
chosen. Because the free elemene as a volatile oil was insoluble 
in water and lighter in density than water, it would float on the 
surface of the aqueous phase. The internal solution of the micro-
emulsion was thus taken to determine the entrapment efficiency. 
2 mL of the elemene microemulsion stored at room temperature 
was moved into a tube as a test sample and set to stand for 2 h. 
Then 0.1 mL of the internal solution of the test sample was taken 
out and diluted to 50 mL with the mobile phase to be measured 
for the β-elemene content as “a”. Then 1.9 mL of the remaining 
solution of the test sample was diluted to 50 mL with the mobile 
phase, 1 mL of this diluted solution above was taken out and 
diluted again to 25 mL to be measured for the β-elemene content 
as “b”. After repeated once as above, the average entrapment 
efficiency (EE) was calculated by the following formula:
Cinternal =a * 50/0.1, Wentrapment = Cinternal * (2 mL - Vfree) 
= 500 * a * (2 mL - Vfree), 
Wtotal = a * 50 + b * 25 * 50.
EE = Wentrapment/Wtotal * 100% = 10 * a 
* (2 - Vfree)/(a + 25b) * 100%.
Vfree is the volume of elemene oil at liquid surface. As 
the oil phase was found to be insignificant in volume on the 
surface of the elemene microemulsion (at least ,0.05 mL), 
EE should be more than 19.5 * a/(a + 25b) * 100%.
Oral relative bioavailability of elemene 
microemulsion in rats
For the pharmacokinetics study, 90 Sprague Dawley rats 
weighing 140–200 g of both sexes were divided randomly 
into an elemene microemulsion group (45 rats) and an 
elemene emulsion group (45 rats) for oral administration 
by 100 mg/kg in elemene content. 3–5 mL of blood was 
drawn from femoral artery of rats at 0, 0.5, 1, 1.5, 2, 2.5, 
3, 4, 6, 8, 10, 12, 14, 18, 24 h after administration (3 rats 
were used for each time point in each group). Then plasma 
was obtained after centrifuged for 10 min at 2000× g and 
4°C, and stored at 4°C. A mixture of 0.5 mL of plasma 
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Figure 1 The three-dimensional response surface diagram of elemene microemulsion 
drawn by Mathcad software using the minimal amount of polysorbate 80 for forming 
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and 1 mL of acetonitrile was oscillated for 5 min, set to 
stand for 5 min and then centrifuged for 30 min at 14000× g 
and 25°C. The supernatant was taken and filtrated with 
  disposable needle filters (0.22 µm). The filtrate was used 
for the content determination of β-elemene in plasma. 
Pharmacokinetic software DAS 2.0 was used for calculating 
pharmacokinetic parameters. Using UFLC detection, the 
standard curve of β-elemene concentration in plasma was 
linear in the range of 0.26–3.94 µg⋅mL-1 with a regression 
equation of Y= 2263.19 * C - 27.11 (r = 0.9995).
statistic analysis
Statistic analysis of the standard curve was carried out by 
OriginPro 7.5 software in fit linear moment. Statistic analysis 
of the pharmacokinetic study was carried out by DAS 2.0 
software (Drug and Statistics software, Drug clinical research 
center, Shanghai University of Traditional Chinese Medicine, 
 Shanghai, China) in statistical or compartmental moment. 
A value of P , 0.05 was regarded as a significant difference.
Results and discussion
characterization of elemene 
microemulsion
Many studies have shown that microemulsion may protect 
unstable drugs, increase the solubility of some insoluble drugs, 
improve bioavailability, control drug release, and reduce 
individual differences of drugs.5 The elemene   microemulsion 
was characterized as (57.7 ± 2.8) nm in size (Figure 2), 
0.485 ± 0.032 in polydispersity index, (3.2 ± 0.4) mv in 
zeta potential, (5.19 ± 0.08) in pH, 6 mpa⋅s in viscosity, and 
(31.8 ± 0.3) mN⋅m-1 in surface tension.   Examination of the 
elemene microemulsion prepared in this work under cross-
polarized light microscopy showed a dark field indicating an 
isotropic system. A 20-fold dilution of this microemulsion 
with water remained visually clear and dark under cross-
polarized light microscope, indicating an excellent dispers-
ing and isotropic stability. The elemene microemulsion as a 
clarified and isotropic system containing 1% elemene (w/v), 
5% ethanol (v/v), 15% propylene glycol (v/v), 15% glycerol 
(v/v), and 5% polysorbate 80 (w/v) shows a formulation of 
weak acidity, low viscosity, and low surface tension that is suit-
able for oral administration. Generally speaking, 5% ethanol 
(v/v), 15% propylene glycol (v/v), 15% glycerol (v/v), and 
5% polysorbate 80 (w/v) could be tolerated by patients and 
pharmaceutical regulations. While mixing method was often 
used for the preparation of microemulsion, we found that it 
was easier to prepare an elemene microemulsion of greater 
clarity with ultrasonication in an ultrasonic bath, especially 
when working around boundary conditions. In addition, the 
ultrasonication method can be easily adapted for production 
of elemene microemulsion at an industrial scale.
stability of elemene microemulsion
When centrifuged at 25°C and 3000× g and 50000× g 
  respectively for 30 min, the phase separation was found 
in the case of the elemene emulsion, but not in the case of 
the elemene microemulsion indicating an excellent phase 
stability of the microemulsion.
Content and entrapment efficiency  
of β-elemene in elemene microemulsion
Currently gas chromatography or liquid chromatography 
technology is used for the content determination of elemene. 
During the samples preparation for gas chromatography, 
elemene is extracted from samples, dried and then dissolved 
again.12 Because elemene is a volatile oil and may be 
vaporized during the drying process, the quantitative result 
may not be accurate. This drying is not required in liquid 
chromatography for the analysis of drug content in elemene 
samples. In this work, UFLC was used to determine the 
drug concentration in the elemene preparations and rat 
plasma after oral administration. The content of β-elemene 
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in the elemene microemulsion was determined to be 
(8.273 ± 0.018) mg⋅mL-1.
Elemene is a volatile oil insoluble in water and lighter 
in density than water that the free elemene in an elemene 
microemulsion should float on the water surface. We failed 
to separate and determine the free elemene by dextran gel 
  column chromatography, because insoluble elemene floated 
on the water or may be adsorbed to the gel particles.   Therefore, 
the entrapment efficiency of elemene microemulsion was 
obtained by examining the drug concentration of the internal 
and total solutions using the liquid surface method. The 
average entrapment efficiency of β-elemene was determined 
to be (99.81% ± 0.24%).
Plasma concentration-time curve 
and relative bioavailability of elemene 
microemulsion
In the process of plasma samples treatment we found that the 
filter adsorption of drug on the 0.22 µm filter was 3.6% and 
the extraction recovery of drug in plasma was 86.1%. In the 
content determination of plasma samples, we found that the 
drug concentrations in plasma after oral administration of the 
elemene emulsion and microemulsion were very low. So, it 
was necessary to increase the ratio of plasma to acetonitrile 
in order to achieve a greater amount of elemene for detection. 
And 3–5 mL of blood was taken to obtain a sufficiently high 
drug concentration. After oral administration in rats, the fit-
ting results of compartment model for the pharmacokinetic 
parameters of the elemene microemulsion were poor so that 
statistical moment method had to be used for calculating the 
pharmacokinetic parameters. The plasma concentration-time 
curves of the elemene microemulsion and emulsion are shown 
in Figure 3. The pharmacokinetic parameters were calculated 
by statistical moment as shown in the table insert. The result 
shows that the area under the concentration-time curves from 
0 h to 24 h (AUC0→24h) of the elemene emulsion and micro-
emulsion was 1.896 mg⋅h⋅L-1 and 3.092 mg⋅h⋅L-1 respectively, 
yielding a relative bioavailability of 163.1%. The Cmax of the 
elemene microemulsion was 1.820 mg.L-1 and 1.3 times of 
the elemene emulsion. The MRT (mean residence time) of 
the elemene microemulsion was 1.668 h, greater than that 
of the elemene emulsion. But the standard deviations of the 
average drug concentrations were relatively large indicating 
large individual differences for oral absorption.
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In other studies docetaxel o/w microemulsion is 
reported to have a relative bioavailability of 519.2% over 
taxotere,6 while the relative bioavailabity of cyclosporine 
microemulsion was enhanced with a 16% to 31% increase 
in AUC and a 32% to 42% increase in Cmax.
13 Our findings 
with elemene microemulsion in this work were in agreement 
with the literature reports. Although the enhanced extent of 
bioavailability of the elemene microemulsion is a little less 
than desired, the surfactant content used is a little lower.6,13,14 
These results encourage further development of elemene 
microemulsions as an oral drug delivery system.
Conclusion
This study shows that the elemene o/w microemulsion with 
good clarity, excellent stability, high entrapment efficiency, 
and improved bioavailability can be prepared successfully 
using elemene as the oil phase and drug, polysorbate 80 as the 
surfactant along with ethanol, propylene glycol, glycerol as the 
cosurfactants, and ultrasonication as the dispersing force.
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